Literature DB >> 2943805

Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.

P Christadoss, J M Lindstrom, N Talal, C R Duvic, A Kalantri, M Shenoy.   

Abstract

The role of lymphokines secreted by acetylcholine receptor (AChR)-reactive lymphocytes in the regulation of an autoimmune response to AChR has not been studied in the human or murine model of myasthenia gravis. We investigated whether AChR-immune lymphocytes derived from mice with experimental autoimmune myasthenia gravis (EAMG) can produce an AChR-specific, genetically controlled soluble factor with biologic activity. AChR-reactive lymphocytes of mice with EAMG secreted an AChR-specific helper factor in vitro, which induced proliferation of AChR-immune but not Mycobacterium tuberculosis-immune lymphocytes. Recombinant, I-A mutant, and monoclonal anti-I-A antibody analyses suggest that AChR-specific helper factor-induced lymphocyte proliferation is controlled by an immune response gene at the I-A subregion of the murine major histocompatibility complex, and is mediated by the I-A molecule.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943805

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Experimental autoimmune myasthenia gravis in the mouse.

Authors:  B Wu; E Goluszko; P Christadoss
Journal:  Curr Protoc Immunol       Date:  2001-05

2.  Ek alpha transgene in B10 mice suppresses the development of myasthenia gravis.

Authors:  P Christadoss; C S David; M Shenoy; S Keve
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice.

Authors:  Richard F Jones; Joyce D Reyes; Heather M Gibson; Jennifer B Jacob; Ulka Vaishampayan; Stuart Ratner; Kang Chen; Wei-Zen Wei
Journal:  Cancer Immunol Immunother       Date:  2019-06-08       Impact factor: 6.968

4.  Myasthenia gravis induces the activation and maturation of lymphocytes in thymoma.

Authors:  K Takahashi; Y Monden; S Saito; Y Kamamura; T Uyama
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

Review 5.  Evolution of animal models in cancer vaccine development.

Authors:  Wei-Zen Wei; Richard F Jones; Csaba Juhasz; Heather Gibson; Jesse Veenstra
Journal:  Vaccine       Date:  2015-08-01       Impact factor: 3.641

6.  Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity.

Authors:  Jennifer B Jacob; Elena Quaglino; Olga Radkevich-Brown; Richard F Jones; Marie P Piechocki; Joyce D Reyes; Amy Weise; Augusto Amici; Wei-Zen Wei
Journal:  Cancer Res       Date:  2010-01-01       Impact factor: 12.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.